RANITIDINE Tablets — Class II drug recall D-0914-2018
Terminated recall by Mckesson Packaging Services, reported 2018-03-14, distributed nationwide. Failed Stability Specifications
| Recall number | D-0914-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Packaging Services, Concord, NC, United States |
| Recall initiated | 2018-02-26 |
| Classified | 2018-07-09 |
| Reported by FDA | 2018-03-14 |
| Terminated | 2020-09-15 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 63739-0489-10 |
| Lot numbers | 0113064, 0114628, 0115189, 0115462 |
| Expiration dates | 2018-03, 2018-08, 2018-09 |
Product
RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10
Reason for recall
Failed Stability Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0914-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.